HOSE - 01/12/2022 3:57:00 PM
The Board resolution dated November 29, 2022, the Board of Directors of Imexpharm Corporation approved to use the Development Investment Fund to compensate for the Conpany’s operating expenses in 2022 with total amount of VND10,560,521,135.
Các tin liên quan
09/02/2023 SMA: New website address
09/02/2023 PNJ: Change in personnel
09/02/2023 SJS: Transferring shares
09/02/2023 MSN: Approval of facility agreement and guarantee agreement
09/02/2023 NHT: Resolution on the liquidity of fixed asset
09/02/2023 NHT: Resolution on the purchase of the used car
09/02/2023 STB.VCSC.M.Au.T.A4: Report on distribution result of covered warrant
09/02/2023 STB.ACBS.Call.EU.Cash.9M.31: Notice of issue of covered warrant
09/02/2023 VND: Approving the transaction with related parties in 2023
09/02/2023 PTB: Reminder of information disclosure